<DOC>
	<DOCNO>NCT02342158</DOCNO>
	<brief_summary>PERMED01 prospective monocenter clinical trial aim evaluate number patient locally advanced metastatic cancer identification molecular alteration tumor sample lead delivery target therapy . PERMED01 enroll 460 patient 3 year .</brief_summary>
	<brief_title>Identifying Molecular Alterations Guide Individualized Treatment Advanced Solid Tumors</brief_title>
	<detailed_description />
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>Age &gt; 18 year Histological diagnosis cancer Locally advance metastatic , biopsiable disease ECOG Performans Status â‰¤2 Affiliation social security Signed inform consent . Emergency , Individually deprive liberty place authority tutor Patients symptomatic progressive brain metastasis Patients bone and/or brain metastasis Pregnant breastfeed woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>